Report on HIV Prevention Research Funding Says New Investment Critical to Capitalize on HIV Prevention Research Breakthroughs

The HIV Vaccines and Microbicides Resource Tracking Working Group released its seventh report on HIV prevention research funding, which states that new investment is critical to capitalizing on HIV prevention breakthroughs. The full report is available here:

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account